POCARED Diagnostics is an in vitro diagnostics company developing a microbiology platform. The companys P-1000 is an automated rapid system that employs intrinsic fluorescence, optical data analysis, and artificial intelligence methods to analyze the multidimensional optical characteristics of microorganisms. The system captures emitted light from the interaction between photons and molecules to detect the pathogens unique optical properties, and an algorithm determines the results.
POCAREDs SP is a highly efficient, general-use, rapid-filtration-based fractionation concentration platform. It concentrates biological particles suspended in liquid form from a feed suspension, and cells of interest are detached intact from the membrane using a wet foam formulation. POCAREDs SP system aims to deliver high rates of cell recovery and viability.
Cumulative Funding Raised Over Time ($)
Employees Over Time
POCARED Diagnostics Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
May 12, 2022
www.prnewswire.com
Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system
#Investment
Jul 1, 2021
www.prnewswire.com
POCARED Diagnostics Secures $50 Million Capital Commitment From GEM as Company envisages going public via SPAC merger
#Investment
Aug 9, 2020
techtime.co.il
אלרון ו-RDC מכרו את פוקרד לנפתלי השקעות - Techtime - חדשות אלקטרוניקה והייטק
Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system
#Investment
Jul 1, 2021
www.prnewswire.com
POCARED Diagnostics Secures $50 Million Capital Commitment From GEM as Company envisages going public via SPAC merger
#Investment
Aug 9, 2020
techtime.co.il
אלרון ו-RDC מכרו את פוקרד לנפתלי השקעות - Techtime - חדשות אלקטרוניקה והייטק